Rosacea
- 22 October 2009
- journal article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 7 (11), 996-1003
- https://doi.org/10.1111/j.1610-0387.2009.07119.x
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosaceaJournal of the American Academy of Dermatology, 2007
- Tetracyclines: Nonantibiotic properties and their clinical implicationsJournal of the American Academy of Dermatology, 2006
- A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosaceaJournal of the American Academy of Dermatology, 2005
- Rosacea: II. TherapyJournal of the American Academy of Dermatology, 2004
- Rosacea: I. Etiology, pathogenesis, and subtype classificationJournal of the American Academy of Dermatology, 2004
- Tacrolimus effect on rosaceaJournal of the American Academy of Dermatology, 2004
- The role of free oxygen radicals in the aetiopathogenesis of rosaceaClinical and Experimental Dermatology, 2003
- Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosaceaJournal of the American Academy of Dermatology, 2001
- A clinical and histopathologic study of granulomatous rosaceaJournal of the American Academy of Dermatology, 1991
- Effect of nadolol on flushing reactions in rosaceaJournal of the American Academy of Dermatology, 1989